Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(Dichloromethyl)pyridine HCl, also known as 3-(Dichloromethyl)pyridine hydrochloride, is a chemical compound that features a pyridine ring attached to a dichloromethyl group, along with a hydrochloride group. As a hydrochloride salt, this compound is typically more soluble in water than the corresponding free base. The combination of a pyridine ring and a dichloromethyl group suggests potential applications in medicinal or organic chemistry, given the prevalence of these structures in pharmaceuticals and biologically active compounds. However, specific characteristics such as color, melting or boiling point, toxicity, and flammability may differ based on the preparation method or purity of the sample.

1010-48-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1010-48-6 Structure
  • Basic information

    1. Product Name: 3-(DICHLOROMETHYL)PYRIDINE HCL
    2. Synonyms: 3-(DICHLOROMETHYL)PYRIDINE HCL;3-Methyl-3-phenylbutyric acid;3-methyl-3-phenylbutanoic acid(SALTDATA: FREE);.beta.-Phenylisovaleric acid;3-Phenylisopentanoic acid;Benzenepropanoic acid, .beta.,.beta.-dimethyl-;Benzenepropanoic acid, beta,beta-dimethyl- (9CI);beta,beta-Dimethylbenzenepropanoic acid
    3. CAS NO:1010-48-6
    4. Molecular Formula: C11H14O2
    5. Molecular Weight: 178.23
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1010-48-6.mol
  • Chemical Properties

    1. Melting Point: 60°C
    2. Boiling Point: 270.46°C (rough estimate)
    3. Flash Point: 183.8 °C
    4. Appearance: /
    5. Density: 1.0292 (rough estimate)
    6. Vapor Pressure: 0.00122mmHg at 25°C
    7. Refractive Index: 1.5182 (estimate)
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: 4.69±0.10(Predicted)
    11. CAS DataBase Reference: 3-(DICHLOROMETHYL)PYRIDINE HCL(CAS DataBase Reference)
    12. NIST Chemistry Reference: 3-(DICHLOROMETHYL)PYRIDINE HCL(1010-48-6)
    13. EPA Substance Registry System: 3-(DICHLOROMETHYL)PYRIDINE HCL(1010-48-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1010-48-6(Hazardous Substances Data)

1010-48-6 Usage

Uses

Used in Medicinal Chemistry:
3-(Dichloromethyl)pyridine HCl is used as a building block or intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. The presence of the dichloromethyl group may allow for the creation of novel chemical entities with unique therapeutic properties.
Used in Organic Chemistry:
3-(Dichloromethyl)pyridine HCl is used as a reagent or catalyst in organic synthesis processes, where the dichloromethyl group can participate in reactions such as nucleophilic substitutions, addition reactions, or rearrangements, leading to the formation of a wide range of organic compounds.
Used in Research and Development:
3-(Dichloromethyl)pyridine HCl is used as a research compound in academic and industrial laboratories to study its chemical properties, reactivity, and potential applications in the synthesis of complex molecules, including those with potential biological activity.

Check Digit Verification of cas no

The CAS Registry Mumber 1010-48-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,1 and 0 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1010-48:
(6*1)+(5*0)+(4*1)+(3*0)+(2*4)+(1*8)=26
26 % 10 = 6
So 1010-48-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H14O2/c1-11(2,8-10(12)13)9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H,12,13)

1010-48-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-3-phenylbutanoic acid

1.2 Other means of identification

Product number -
Other names 3-phenyl-3-methylbutanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1010-48-6 SDS

1010-48-6Relevant articles and documents

Steric Effects. A Study of a Rationally Designed System

Bott, Garry,Field, Leslie D.,Sternhell, Sever

, p. 5618 - 5626 (1980)

The principles for the rational design of systems suitable for the study of steric effects are defined.A suitable molecular framework was synthesized and a study of internal rotaition by dynamic NMR spectroscopy (DNMR) 0f 33 derivatives, differing principally in the nature of the molecular fragment (X), showed the following. (i) For 1 (Y = Me; X = halogen) the rotaition barriers (ΔG excit.) increase smoothly and monotonically with the van der Waals radius of X (rx), which permits the estimation of effective rx for fragments of lower symmetry. (ii) The rotational barriers are the sum of additive contributions, designated interference values (IH-X), which can be used to predict the rotational barriers in 2,2'-disubstituted biphenyls. (iii) A simple geometrical parameter, apparent overlap (r*), which is related to the distortion of the framework in the transition state, is proposed and found to have an excellent linear correlation with the barrier to rotation in 2,2'-disubstituted biphenyls. (iv) This correlation can be used for a semiquantitative estimation of rotational barriers in biaryls and other systems.

Oxygen Rearrangement of Molecular Ions of 3-Phenylpropionates

Liehr, Joachim G.,Caprioli, Richard M.,Beynon, John H.,Morgan, Roger P.,Richter, Wilhelm J.

, p. 157 - 160 (1980)

The oxygen rearrangement in molecular ions of 3-phenylpropionates has been investigated with the aid of mass analyzed ion kinetic energy spectra.Elimination of an allyl radical followed by expulsion of ketene from the molecular ion of allyl 3-phenylpropionate is shown to result in formation of protonated benzaldehyde.The oxygen rearrangement has been found to be inoperative in ionized methyl 3-methyl-3-phenylbutyrate. + ions in the spectrum of the latter compound are formed by elimination of the 3-methyl substituent and subsequent methoxy migration.

MALIC ENZYME INHIBITORS

-

Page/Page column 110-111, (2021/04/23)

The present invention relates to novel compounds useful as malic enzyme (ME) inhibitors, processes for their preparation and use of these compounds for the therapeutic treatment of disorders mediated by ME such as cancers (e.g. pancreatic ductal adenocarcinoma (PDAC)) in humans.

Umpolung Strategy for Arene C?H Etherification Leading to Functionalized Chromanes Enabled by I(III) N-Ligated Hypervalent Iodine Reagents

Mikhael, Myriam,Guo, Wentao,Tantillo, Dean J.,Wengryniuk, Sarah E.

supporting information, p. 4867 - 4875 (2021/09/14)

The direct formation of aryl C?O bonds via the intramolecular dehydrogenative coupling of a C?H bond and a pendant alcohol represents a powerful synthetic transformation. Herein, we report a method for intramolecular arene C?H etherification via an umpoled alcohol cyclization mediated by an I(III) N-HVI reagent. This approach provides access to functionalized chromane scaffolds from primary, secondary and tertiary alcohols via a cascade cyclization-iodonium salt formation, the latter providing a versatile functional handle for downstream derivatization. Computational studies support initial formation of an umpoled O-intermediate via I(III) ligand exchange, followed by competitive direct and spirocyclization/1,2-shift pathways. (Figure presented.).

AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN

-

Paragraph 0181, (2021/08/05)

The present invention relates to new compounds that show pharmacological activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the μ-opiod receptor (MOR or mu-opioid). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.

The antibody-drug conjugate hemiasterlin derivatives and their pharmaceutically (by machine translation)

-

Paragraph 0399-0400, (2020/12/01)

[Problem] to give one specific target cell cytotoxic, normal cells to the cytotoxic is suppressed, the antibody-drug conjugate medicine hemiasterlin derivatives. (2) Formula [a]:[In the formula, mAb antibody expressed, q is 1 - 8 represents an integer of, h are 1 - 5 represents an integer of, g is an alanine residue (Ala) to represent, g is 1 - 4 represents an integer of, Y is a single bond or a formula (Y-a 1) is represented by the group, Z is formula (Z-a 1), equation (Z-a 2), equation (Z-a 3), formula (Z-a 4), formula (Z-a 5), type (Z-a 6), formula (Za-a 1), equation (Za-in 2), equation (Za-a 3), formula (Za-a 4), formula (Za-a 5), type (Za d 6), formula (Za-a 7), type (Za-in 8), or a group represented by formula (Za-a 10) (Za-a 9) formula a] is expressed by, antibody-drug conjugate or its pharmaceutically acceptable salt containing a drug. [Drawing] no (by machine translation)

MEDICINE CONTAINING ANTIBODY DRUG CONJUGATE CONTAINING HEMIASTERLIN DERIVATIVE

-

Paragraph 0366-0367, (2020/12/01)

PROBLEM TO BE SOLVED: To provide medicines containing an antibody drug conjugate containing a hemiasterlin derivative, in which specific cytotoxicity to target cells is given, while cytotoxicity to normal cells is suppressed. SOLUTION: Provided is a medicine represented by formula (2-1), and containing an antibody drug conjugate or a pharmaceutically acceptable salt thereof [where, mAb represents an antibody, q represents an integer from 1 to 8, b represents an integer from 1 to 5, Z is a group represented by formula (Z-1), formula (Z-2), formula (Z-3), formula (Za-1), formula (Za-2), formula (Za-3), formula (Za-4), or formula (Za-5)]. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

Synthesis of Amides and Esters by Palladium(0)-Catalyzed Carbonylative C(sp3)?H Activation

?arny, Tomá?,Baudoin, Olivier,Clemenceau, Antonin,Rocaboy, Ronan

, p. 18980 - 18984 (2020/09/01)

The 1,4-palladium shift strategy allows the functionalization of remote C?H bonds that are difficult to reach directly. Reported here is a domino reaction proceeding by C(sp3)?H activation, 1,4-palladium shift, and amino- or alkoxycarbonylation, which generates a variety of amides and esters bearing a quaternary β-carbon atom. Mechanistic studies showed that the aminocarbonylation of the σ-alkylpalladium intermediate arising from the palladium shift is fast using PPh3 as the ligand, and leads to the amide rather than the previously reported indanone product.

Sodium Methyl Carbonate as an Effective C1 Synthon. Synthesis of Carboxylic Acids, Benzophenones, and Unsymmetrical Ketones

Hurst, Timothy E.,Deichert, Julie A.,Kapeniak, Lucas,Lee, Roland,Harris, Jesse,Jessop, Philip G.,Snieckus, Victor

supporting information, p. 3882 - 3885 (2019/06/07)

Reported is the synthesis of carboxylic acids, symmetrical ketones, and unsymmetrical ketones with selectivity achieved by exploiting the differential reactivity of sodium methyl carbonate with Grignard and organolithium reagents.

Copper-Mediated, Heterogeneous, Enantioselective Intramolecular Buchner Reactions of α-Diazoketones Using Continuous Flow Processing

Crowley, Daniel C.,Lynch, Denis,Maguire, Anita R.

, p. 3794 - 3805 (2018/04/14)

Enantioselective intramolecular Buchner reactions of α-diazoketones can be effected using heterogeneous copper-bis(oxazoline) catalysts in batch or using continuous flow processing in up to 83% ee. The catalyst can be reused up to 7 times without loss of activity. For α-diazoketones 3 and 4, the enantioselection achieved in flow with the immobilized catalyst was comparable with the standard homogeneous catalyzed process.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1010-48-6